Phil Skolnick - 09 Jan 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Chief Scientific Officer
Signature
/s/ Phil Skolnick
Issuer symbol
N/A
Transactions as of
09 Jan 2023
Net transactions value
-$7,454
Form type
4
Filing time
09 Jan 2023, 16:11:54 UTC
Previous filing
05 Jan 2023
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $7,454 -369 -1.6% $20.20 22,028 09 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.